Effects of N-acetylcysteine on microalbuminuria and organ failure in acute severe sepsis: Results of a pilot study

Chest

Volumn 127, Issue 4, 2005, Pages 1413-1419

  Spapen, Herbert D ^a   Diltoer, Marc W ^a   Nguyen, Duc N ^a   Hendrickx, Inne ^a   Huyghens, Luc P ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Antioxidants; Cardiac performance; Microalbuminuria; N acetylcysteine; Organ failure; Severe sepsis

Indexed keywords

ACETYLCYSTEINE; CREATININE; PLACEBO;

ADULT; AGED; ARTICLE; CAPILLARY LEAK SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; MALE; MICROALBUMINURIA; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEPSIS; URINALYSIS; ACUTE DISEASE; ALBUMINURIA; HOSPITALIZATION; MIDDLE AGED; PILOT STUDY;

ACETYLCYSTEINE; ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PILOT PROJECTS; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 19044376964     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.4.1413     Document Type: Article

References (45)

1. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150
2. Gosling P, Sanghera K, Dickson G. Generalized vascular permeability and pulmonary function in patients following serious trauma. J Trauma 1994; 36:477-481
3. Fleck A, Raines G, Hawker F, et al. Increased vascular permeability: a major cause of albuminuria in disease and injury. Lancet 1985; 781-783
4. Gosling P, Hughes EA, Reynolds TM, et al. Microalbuminuria is an early response following acute myocardial infarction. Eur Heart J 1991; 12:508-513
5. Abid O, Sun Q, Sugimoto K, et al. Predictive value of microalbuminuria in medical ICU patients: results of a pilot study. Chest 2001; 120:1984-1988
6. Gosling P, Brudney S, Mc Grath L, et al. Mortality prediction at admission to intensive care: a comparison of microalbuminuria with acute physiology scores after 24 hours. Crit Care Med 2003; 31:98-103
7. Goode HF, Cowley HC, Walker BE, et al. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995; 23:646-651
8. Aruoma OI, Halliwell B, Hoey BM, et al. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989; 6:593-597
9. Bernard GR. N-acetylcysteine in experimental and clinical acute lung injury. Am J Med 1991; 91:54S-59S.
10. Kharazmi A, Nielsen H, Schiotz PO. N-acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolism. Int J Immunopharmacol 1988; 10:39-46
11. Fox ES, Brower JS, Bellezzo JM, et al. N-acetylcysteine and α-tocopherol reverse the inflammatory response in activated rat Kupffer cells. J Immunol 1997; 158:5418-5423
12. Faruqi RM, Poptic EJ, Faruqi TR, et al. Distinct mechanisms for N-acetylcysteine inhibition of cytokine-induced E-selectin and VCAM-1 expression. Am J Physiol 1997; 273:H817-H826
13. Zhang H, Spapen H, Nguyen DN, et al. Protective effects of N-acetylcysteine in endotoxemia. Am J Physiol 1994; 266:H1746-H1754
14. Hashimoto S, Gon Y, Matsumoto K, et al. N-acetylcysteine attenuates TNF-α-induced p38 MAP kinase activation and p38 MAP kinase-mediated IL-8 production by human pulmonary vascular endothelial cells. Br J Pharmacol 2001; 132:270-276
15. Paterson RL, Galley GF, Webster NR. The effect of N-acetylcysteine on nuclear factor-κB activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Grit Care Med 2003; 31:2574-2578
16. Carbonell LF, Nadal JA, Llanos MC, et al. Depletion of liver glutathione potentiates the oxidative stress and decreases nitric oxide synthesis in a rat endotoxin shock model. Crit Care Med 2000; 28:2002-2006
17. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
18. Poelaert J, Declerck C, Vogelaers D, et al. Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 1997; 23:553-560
19. Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22:707-710
20. Alonso de Vega JM, Diaz J, Serrano E, et al. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 2002; 30:1782-1786
21. Motoyama T, Okamoto K, Kukita I, et al. Possible role of oxidative stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 2003; 31:1048-1052
22. Schmidt H, Schmidt W, Muller T, et al. N-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo. Crit Care Med 1997; 25:858-863
23. Thorevska N, Sabahi R, Upadya A, et al. Microalbuminuria in critically ill medical patients: prevalence, predictors, and prognostic significance. Crit Care Med 2003; 31:1075-1081
24. De Gaudio AR, Adembri C, Grechi S, et al. Microalbuminuria as an early index of impairment of glomerular permeability in postoperative septic patients. Intensive Care Med 2000; 26:1364-1368
25. Molnar Z, Szakmany T, Heil P. Microalbuminuria does not reflect increased systemic capillary permeability in septic shock. Intensive Care Med 2003; 29:391-395
26. Peake SL, Moran JL, Leppard PI. N-acetylcysteine depresses cardiac performance in patients with septic shock. Crit Care Med 1996; 24:1302-1310
27. Molnar Z, Shearer E, Lowe D. N-acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study. Crit Care Med 1999; 27:1100-1104
28. Walsh TS, Hopton P, Philips BJ, et al. The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure. Hepatology 1998; 27:1332-1340
29. Spapen HD, Nguyen DN, Vereist K, et al. N-acetylcysteine and cardiac dysfunction in human septic shock. Clin Intensive Care 2002; 13:27-32
30. Prescott LF, Donovan JW, Jarvie DR, et al. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989; 37:501-506
31. Ortolani O, Conti A, De Gaudio AR, et al. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am J Respir Crit Care Med 2000; 161:1907-1911
32. Laurent T, Markert M, Feihl F, et al. Oxidant-antioxidant balance in granulocytes during ARDS: effect of N-acetylcysteine. Chest 1996; 109:163-166
33. Spies CD, Reinhart K, Witt I, et al. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. Crit Care Med 1994; 22:1738-1746
34. Rank N, Michel C, Haertel C, et al. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double blind study. Crit Care Med 2000; 28:3799-3807
35. Spapen H, Zhang H, Demanet C, et al. Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Chest 1998; 113:1616-1624
36. Agusti AGN, Togores B, Ibanez J, et al. Effects of N-acetyl-cysteine on tissue oxygenation in patients with multiple organ failure and evidence of tissue hypoxia. Eur Respir J 1997; 10:1962-1966
37. Kern H, Wittich R, Rohr U, et al. Increased endothelial injury in septic patients with coronary artery disease. Chest 2001; 119:874-883
38. Creager MA, Roddy MA, Boles K, et al. N-acetylcysteine does not influence the activity of endothelium-derived relaxing factor in in vivo. Hypertension 1997; 29:668-672
39. Harrison P, Wendon J, Williams R. Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure. Hepatology 1996; 23:1067-1072
40. 2+ in cardiac myocytes. Circ Res 1997; 81:1011-1020
41. Gross WL, Bak MI, Ingwall JS, et al. Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve. Proc Natl Acad Sci U S A 1996; 93:5604-5609
42. 2+ sensitivity but normal mitochondrial function in septic heart. Am J Respir Crit Care Med 2001; 163:362-367
43. Heller AR, Groth G, Heller SC, et al. N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients. Crit Care Med 2001; 29:272-276
44. Sprong RC, Winkelhuyzen-Janssen, Aarsman CJM, et al. Low-dose N-acetylcysteine protects rats against endotoxin-mediated oxidative stress, but high-dose increases mortality. Am J Respir Crit Care Med 1998; 157:1283-1293
45. Ritter C, Andrades ME, Reinke A, et al. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med 2004; 32:342-349